Pennsylvania’s health department put the 2026 measles count at 1,078 cases as of October 7, with 1,066 of them tied to a single outbreak that started in Lebanon County in late April, Ars Technica reported citing the state’s own tally. That makes it the largest measles outbreak the US has recorded since the virus was declared eliminated here in 2000, and the largest single outbreak since a 1990–91 epidemic centered on Philadelphia infected about 1,400 people, according to ABC News. Twelve of this year’s Pennsylvania cases, logged in January and March, predate the outbreak and aren’t counted in the 1,066.
Six days earlier, on October 1, state officials put the figure at 943 cases and the same five deaths, as covered at the time in an earlier count of the outbreak. That’s 135 more cases in six days, or 22 a day, with no sign of flattening: 145 cases were added in the most recent seven-day window Ars tracked. The health department also flagged that 40 of the 74 cases reported since the prior Monday update were infections identified more than two weeks earlier — a reporting lag that means every weekly total understates how bad the week actually was, and that the real-time count is always running behind the virus.
Who gets sick, who dies
Of the 1,066 outbreak cases, 207 required hospitalization and five people died: a newborn, a 6-week-old infant, an 18-year-old, a 20-year-old and a 40-year-old. All five were unvaccinated; the two infants were too young to have received a shot. One of the adult deaths, the Inquirer reported, was a 20-year-old Amish woman being treated for leukemia — she had wanted the MMR vaccine, but her doctor withheld it because chemotherapy had suppressed her immune system, and measles swept through her unvaccinated household.
Why Lancaster County
Lancaster County, home to the country’s largest Amish and Old Order Mennonite populations, accounts for 391 of the state’s cases, the most of any county; Mifflin County is second with 118. Pennsylvania’s statewide MMR vaccination rate is about 93%, according to History of Vaccines, but some Lancaster-area classrooms sit at 50% to 60%. Measles has a basic reproduction number around 12 to 18 — one infected person can seed that many secondary cases in a fully susceptible population — which is why the herd-immunity threshold sits at roughly 95% coverage, not the 70% or so that suffices for less contagious diseases. A county average in the low 90s can still hide pockets well under the line, and pockets are all the virus needs.
Pennsylvania’s 1,066 outbreak cases now exceed South Carolina’s 997, the previous post-elimination record, and more than Texas’s 762-case outbreak that ran from January through August 2025. The three outbreaks are not obviously unrelated: the Texas outbreak is the one whose start date, January 20, 2025, anchors the ongoing federal review of whether the virus has become endemic again in the US.
The national backdrop: coverage keeps slipping
The CDC’s own data page listed 3,887 confirmed US measles cases as of October 1, 2026, across 47 jurisdictions, plus 18 cases among international visitors; 42 new outbreaks have been identified this year and 95% of cases — 3,700 of 3,887 — are outbreak-linked. That’s already well past 2025’s 2,289 cases, which was itself the worst calendar year since 1992, and the worst single year since the 1989–91 epidemic that preceded the modern two-dose vaccination schedule.
The mechanism behind that climb is documented in the CDC’s own kindergarten survey: national MMR coverage among kindergartners fell to 92.4% in the 2025–26 school year, down from 95.2% in 2019–20 and from 92.5% the year before, according to CDC SchoolVaxView data. Exemptions from at least one required vaccine hit a record 4.2%, up from 3.6%, rising in 41 states and the District of Columbia; 24 states now report exemption rates above 5%. State MMR coverage ranges from 98.9% in West Virginia to 75.2% in Idaho, and 39 of 50 states fall below the 95% target. The CDC estimates roughly 280,000 kindergartners nationwide lack a documented two-dose MMR series this year.
What the November review actually checks
The US lost nothing automatically when Pennsylvania passed 1,000 cases. Elimination status, as defined by the Pan American Health Organization’s Regional Verification Commission, means the absence of continuous transmission of the same measles genotype for 12 months or more in a country. PAHO’s own account of the review sets the analysis window at exactly one year from January 20, 2025 — the start date of the Texas outbreak — and the question for the Commission is whether genomic sequencing shows an unbroken chain of that same lineage running through South Carolina and into Pennsylvania’s outbreak. The hearing was originally set for April 13, 2026; PAHO pushed it to November, citing the time needed for US authorities to complete full viral genome sequencing and build a bioinformatics pipeline to compare strains, and describing the delay as an effort to “simplify and standardize the assessment process” rather than a postponement forced by the outbreak’s size.
The Americas region as a whole already lost its hemispheric measles-free certification in November 2025, after the same Commission found Canada had sustained endemic transmission for 12 months — the first country in the Americas to do so since the region was certified free of the disease in 2002. The November 2026 session now asks the same question of the US and Mexico individually. Losing elimination status changes no law and triggers no immediate federal action; what it does is formally reclassify the outbreak from an imported flare-up to a resident disease, the distinction the elimination framework exists to draw.
Surveillance gaps complicate even that judgment: undercounting and delayed reporting have made the true death toll and case count hard to pin down nationally, and states have taken divergent approaches to the same epidemic — New York, for instance, has gone as far as declaring a formal disaster while leaning on one of the country’s strictest school vaccine laws. Pennsylvania has run pop-up MMR clinics in the outbreak zone since April, administering around 4,300 doses, per History of Vaccines; whether that catches up with a virus adding 22 cases a day is the number to watch before the Commission convenes.